knowledge -WSS

knowledge

author：knowledge 2025-09-06 04:40:42 - browse：4343

Surgeons prepare the pig kidney for transplantation — Surgeons prepare the gene-edited pig kidney for transplantation at Massachusetts General Hospital. Massachusetts General Hospital

In a new test of xenotransplantation, a medical team at Massachusetts General Hospital announced Thursday that, for the first time, it had transplanted a kidney from a CRISPR gene-edited pig into a living patient.

Surgeons performed the milestone procedure over four hours on Saturday, March 16, without complications. The organ recipient, a 62-year-old man named Richard Slayman, had previously received a human kidney transplant, but it failed after about five years, requiring him to resume kidney dialysis in 2023.

As of Thursday morning, Slayman, a manager with the Massachusetts Department of Transportation, was up and walking — he’s up to 20 laps a day around the ward — one of his physicians told STAT. His kidneys are performing well enough that he hasn’t received dialysis since the surgery, said Leonardo Riella, MGH’s medical director for kidney transplants. He is expected to be discharged soon.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Jerome Adams on the need for new antivirals for Covid
Next article： FDA clears Verve to begin U.S. study of gene

entertainment

WSS

STAT Readout: Friday, Oct. 20 biotech updates

How clinical AI models' predictive power can degrade over time

The future of Biogen: Pragmatism, ‘moonshots,’ and no Twinkies

Is there really a nursing shortage in the U.S.?

Is there really a nursing shortage in the U.S.?

UnitedHealth’s Q3 profit jumps as medical costs rise more slowly

knowledge

knowledge

Wikipedia

How to save PrEP access — and even expand it

Results on Novartis prostate cancer therapy could expand its use

Continuity nursing helped my family in our darkest PICU moments

STAT Readout Newsletter: Today in biotech, life science news

In age of alternative facts, a scholarly course on calling out crap

J&J lung cancer data amount to new salvo against AstraZeneca

DIEP, the 'gold standard' of breast reconstruction, is under threat

UnitedHealth, Optum discontinue NaviHealth name

How to save PrEP access — and even expand it

Better Therapeutics data on benefit with GLP

leisure time

Roche drug slashes death risk in early

How doctors and nurses shape Google's AI

Is there really a nursing shortage in the U.S.?

Merck, Daiichi strike cancer drug pact worth up to $22 billion

Results on Novartis prostate cancer therapy could expand its use

Cassava Sciences’ Alzheimer’s clinical trials should be halted

explore

leisure time

entertainment

hotspot